(Institución)
 
 

Docu-menta >

Statistics

Total Visits

Views
Preclinical studies of efficacy thresholds and tolerability of a clinically ready lentiviral vector for pyruvate kinase deficiency treatment 278

Total Visits per Month

April 2025 May 2025 June 2025 July 2025 August 2025 September 2025 October 2025
Preclinical studies of efficacy thresholds and tolerability of a clinically ready lentiviral vector for pyruvate kinase deficiency treatment 14 15 14 17 20 15 18

File Downloads

Views
23. Navarro- MOL THERAPY MCD 2021.pdf 154

Top Country Views

Views
España 278

Top City Views

Views
Madrid 278

 

Información y consultas: documenta@ciemat.es | Documento legal